On June 2, 2025, Lexicon Pharmaceuticals' stockholders approved increases in share allocations for their 2017 Equity Incentive Plan and Non-Employee Directors’ Plan, allowing for 75 million and 4 million shares respectively. The amendment for a potential reverse stock split was also approved with significant majority votes.